Novartis India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)
Novartis India Ltd · Outcome · 04 Nov 2026, 12:34 am
Novartis India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 561 (-37.9% YoY | -46.0% QoQ) ■ EBITDA: -318 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -56.8 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: -775 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -31.4 (Profit to Loss YoY | Profit to Loss QoQ)
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. · 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. · 06 Nov 2026
- Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026. · 05 Nov 2026
- Outcome of the Board Meeting held today i.e. November 04, 2026 · 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 · 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. · 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
